- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Lung Cancer Small Cell Lung Cancer (SCLC)
Total 14546 results
-
AbbVieActive, not recruitingAdvanced Solid Tumors Cancer | Non Small Cell Lung Cancer (NSCLC)United States, Australia, France, Israel, Japan, Korea, Republic of, Spain, Taiwan
-
Genentech, Inc.CompletedNon-Small Cell Lung Cancer, Metastatic Colorectal Cancer, Metastatic Non Small Cell Lung Cancer, Metastatic Cancers, MelanomaUnited States
-
Yantai LNC Biotechnology Singapore PTE. LTD.Not yet recruiting
-
AstraZenecaActive, not recruitingNon Small Cell Lung Cancer NSCLCPoland, United States, Taiwan, Thailand, Vietnam, Korea, Republic of, United Kingdom, Brazil, Hungary, Japan, Mexico, Peru, Russian Federation, China, Germany, South Africa, Ukraine, Bulgaria, Hong Kong
-
Innovent Biologics (Suzhou) Co. Ltd.CompletedNSCLC (Non-small-cell Lung Cancer)China
-
Palobiofarma SLNovartis; H. Lee Moffitt Cancer Center and Research InstituteCompletedNon-small Cell Lung Cancer (NSCLC)United States
-
Astellas Pharma Global Development, Inc.CompletedNon-Small-Cell Lung Cancer (NSCLC) | Epidermal Growth Factor Receptor MutationsUnited States
-
Henan Cancer HospitalRecruitingAlotinib Plus Durvalumab-Platinum-Etoposide in First-line Treatment Extensive Small-cell Lung CancerSCLC, Extensive StageChina
-
Joel NealTerminatedNeuroendocrine Tumors | Small Cell Lung Cancer (SCLC)United States
-
AmgenNot yet recruitingEarly-stage Non-squamous Non-small Cell Lung Cancer (NSCLC)
-
Merck Sharp & Dohme LLCRecruitingNon-small Cell Lung Cancer (NSCLC)China, Australia, United States, Turkey, Chile, Taiwan, Denmark, France, Spain, Argentina, Italy, Netherlands, Thailand, Korea, Republic of
-
Academic Thoracic Oncology Medical Investigators...AstraZenecaCompletedNon-Small Cell Lung Cancer NSCLCUnited States
-
Samsung Medical CenterAstraZenecaCompletedEfficacy and Safety of 80mg Osimertinib in Patients With Non-small Cell Lung Cancer(NSCLC) (BLOSSOM)Non-small Cell Lung Cancer (NSCLC)Korea, Republic of
-
University Health Network, TorontoCompletedNon Small Cell Lung Cancer (NSCLC)Canada
-
Merck Sharp & Dohme LLCCompleted
-
Maastricht Radiation OncologyAnticancer Fund, Belgium; Reliable Cancer TherapiesTerminatedNon Small Cell Lung Cancer (NSCLC)Netherlands
-
Tasly Pharmaceuticals, Inc.UnknownNon-small Cell Lung Cancer (NSCLC)China
-
The First Affiliated Hospital with Nanjing Medical...RecruitingMetastatic NSCLC | Recurrent NSCLC | Advanced Non-Small Cell Squamous Lung CancerChina
-
Second Affiliated Hospital, School of Medicine,...Tongji Hospital; Qilu Hospital of Shandong University; First Hospital of China... and other collaboratorsRecruitingPembrolizumab | Non-small-lung-cell Cancer, NSCLCChina
-
Beijing Haidian Hospital307 Hospital of PLA; Peking University People's Hospital; 309th Hospital of Chinese...RecruitingThe Role of Icotinib in the Perioperative Treatment of IIIA - IIIB NSCLC Patients With EGFR MutationNon-small Cell Lung Cancer(NSCLC)China
-
Johns Hopkins UniversityAstraZenecaEnrolling by invitationNon-small Cell Lung Cancer (NSCLC)United States
-
Albert Einstein College of MedicineMontefiore Medical CenterActive, not recruitingNon-small Cell Lung Cancer, NSCLCUnited States
-
Fondazione IRCCS Istituto Nazionale dei Tumori,...Active, not recruitingNon Small Cell Lung Cancer (NSCLC)Italy
-
Abramson Cancer Center of the University of PennsylvaniaTerminatedNon-Small Cell Lung Cancer (NSCLC)United States
-
AstraZenecaApproved for marketingNon Small Cell Lung Cancer (NSCLC)Taiwan, Thailand, Turkey, Brazil, Philippines, Russian Federation, Romania, Austria, Hungary, Bulgaria, Latvia, India, Argentina, Australia, Estonia, Malaysia, Mexico, Singapore, South Africa
-
Boehringer IngelheimRecruitingSmall Cell Lung Carcinoma (SCLC)United Kingdom, Germany, France, Poland
-
National Cancer Institute (NCI)CompletedStage IIIA Non-small Cell Lung Cancer | Stage IIIB Non-small Cell Lung Cancer | Extensive Stage Small Cell Lung Cancer | Recurrent Small Cell Lung Cancer | Recurrent Non-small Cell Lung Cancer | Stage IV Non-small Cell Lung CancerUnited States
-
AstraZenecaRecruitingUnresectable /Inoperable Locally Advanced (Stage II-III) Non-small Cells Lung Cancer (NSCLC)Russian Federation
-
University of California, San FranciscoAstraZenecaActive, not recruitingStage IIIA Non-Small Cell Lung Cancer | Stage I Non-Small Cell Lung Cancer | Stage IA Non-Small Cell Lung Cancer | Stage IB Non-Small Cell Lung Cancer | Stage II Non-Small Cell Lung Cancer | Stage IIA Non-Small Cell Lung Cancer | Stage IIB Non-Small Cell Lung CancerUnited States
-
AbbVieAvailableNon-Small Cell Lung Cancer (NSCLC)Australia, Hong Kong, Israel, United States, Germany
-
Promontory Therapeutics Inc.Pfizer; EMD SeronoCompletedNon-Small Cell Lung Cancer (NSCLC)United States, Switzerland
-
Centre Hospitalier Universitaire de NīmesMEDEXPRIM; GRATICULECompletedNon-small Cell Lung Cancer (NSCLC)France
-
Jiangsu HengRui Medicine Co., Ltd.CompletedNon-small Cell Lung Cancer(NSCLC)China
-
Shanghai Yizhong Biotechnology Co., Ltd.UnknownNon-Small Cell Lung Cancer(NSCLC)China
-
Wake Forest University Health SciencesCompletedNon-small Cell Lung Cancer (NSCLC)United States
-
Ethicon Endo-SurgeryCompleted
-
Genzyme, a Sanofi CompanyCompletedNon-Small Cell Lung Cancer (NSCLC, Locally Advanced or Metastatic, Second-lineUnited States, Czech Republic, Hungary
-
Radboud University Medical CenterCompletedNSCLC | Locally Advanced Non-Small Cell Lung CancerNetherlands
-
Joseph J. Cullen, MD, FACSNational Cancer Institute (NCI); National Institutes of Health (NIH); Holden...RecruitingCarcinoma, Non-Small-Cell Lung | Non-Small Cell Lung Cancer | NSCLC | Nonsmall Cell Lung Cancer | Non-Small-Cell Lung CarcinomaUnited States
-
Salma SabbourBristol-Myers Squibb; Rutgers Cancer Institute of New Jersey; BeyondSpring Pharmaceuticals...Active, not recruitingLung Cancer | SCLCUnited States
-
Tang-Du HospitalActive, not recruitingNon-small-cell Lung Cancer (NSCLC)China
-
Ethicon Endo-SurgeryCompletedNon-small Cell Lung Cancer (NSCLC)Korea, Republic of
-
Eckhard PodackWithdrawnNon-Small Cell Lung Cancer | NSCLC | Lung Cancer | Non-small-cell Lung Carcinoma
-
Eli Lilly and CompanyTerminatedSmall Cell Lung Cancer | SCLC | Carcinoma, Small CellNetherlands, Belgium
-
Astellas Pharma Global Development, Inc.TerminatedNon-small Cell Lung Cancer (NSCLC) | Epidermal Growth Factor Receptor (EGFR) MutationsUnited States
-
Memorial Sloan Kettering Cancer CenterCompletedUnresectable or Metastatic Non-small Cell Lung Cancer (NSCLC)United States
-
Shanghai Chest HospitalRecruitingSmall Cell Lung Carcinoma | Small-cell Lung Cancer | Small Cell Lung Cancer Limited Stage | Small Cell Lung Cancer Extensive Stage | Small Cell Lung Cancer, Combined TypeChina
-
University Health Network, TorontoOICRNot yet recruitingNon-Small Cell Lung Cancer (NSCLC) | Clinical Staging T2b-3 N0-1 M0
-
Novartis PharmaceuticalsTerminatedAdvanced Non Small Cell Lung Cancer (NSCLC)France, Italy, Taiwan, Spain, Netherlands, Japan, Hong Kong, Korea, Republic of, Norway, United States, United Kingdom, Poland
-
Biomea Fusion Inc.RecruitingColorectal Cancer | Pancreatic Cancer | NSCLC | Non Small Cell Lung Cancer | Stage III Pancreatic Cancer | Stage IV Pancreatic Cancer | CRC | KRAS Mutation-Related Tumors | Relapsed Cancer | Refractory Cancer | Stage IV Non-small Cell Lung Cancer | Stage IV Colorectal Cancer | Stage III Non-small Cell Lung Cancer | Stage III NSCLC and other conditionsUnited States, Korea, Republic of